Chimeric Antigen Receptor T-Cell therapy (CAR-T) has revolutionized the field of cancer immunotherapy. In order to further optimize this amazing technology, researchers have generated Bispecific CAR's; engineered to resist immune cell evasion and antigen escape in order to kill tumors and prevent the re-emergence of cancerous cells. As a thought leader in the field of immuno-oncology, GenScript has written a review on the various trends in Bispecific CAR-T Therapy.
Providing fully customizable single variable fragment chain synthesis with optimized antigen production and tailored deliverables for every application from in-vivo diagnostics to CAR-T based therapeutics.
Learn MoreAnalyze Phosphorylated Proteins
Phospho-specific mAb and pAb Generation
Pharmacokinetic Analysis
Anti-Idiotype mAb and pAb GenerationStrict Protein Analysis
Traditional & Express mAb GenerationAnalyze Modified Proteins
Traditional & Express pAb GenerationIn-Vitro diagnostics
MonoRab™ Custom Rabbit mAb Generation
